Axonex AI Group Ltd is a Hong Kong-based company strategically focused on artificial intelligence (AI) and robotics, and an established business interior design and fit-out works provider. Through its subsidiary, Axonex AI Limited, and its majority-owned subsidiary, Rice Robotics AGI Holding Limited, the Group delivers robot models and robotics solutions, including the FLOKI Minibot M1 and micro-insurance solutions purpose-built for commercial robots. The Group also maintains its established interior design and fit-out works business. Anchored by its ongoing transformation, Axonex AI is focused on AI and robotics as its main growth-driving engine.
Last trade$0.00
Day change$0.00 (0.00%)
Day range$0.919 – $0.9925
Volume4,347
Market cap$6M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
No ratio data was found for AXNX.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
No quarterly
income statement data was found for AXNX.
Recent news
Company coverage with links to the original publishers.
Axonics received regulatory approval from the Therapeutic Goods Administration in Australia to market its R20 rechargeable sacral neuromodulation (SNM) system, which features a 20-year functional life and reduced recharge frequency. However, Axonics' shares fell despite this positive development.
Axonics' (AXNX) fourth-generation rechargeable Sacral Neuromodulation system will reduce the frequency of patient recharges significantly. The new form factor ensures ease of use.
Analysts' ratings for Axonics (NASDAQ:AXNX) over the last quarter vary from bullish to bearish, as provided by 7 analysts.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
0
6
0
0
Last 30D
0
0
1
0
0
1M Ago
0
0
0
0
0
2M Ago
0
0
5
0
0
3M Ago
1
0
0
0
0
The 12-month price targets, analyzed by analysts, offer insights with an average target of $71.29, a high estimate of $73.00, and a low estimate of $71.00. Witnessing a positive shift, the current average has risen by 0.69% from the previous average price target of $70.80.
Analyzing Analyst Ratings: A Detailed Breakdown
The perception of Axonics by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst
Analyst Firm
Action Taken
Rating
Current Price Target
Prior Price Target
Shagun Singh
RBC Capital
Maintains
Sector Perform
$71.00
-
David Rescott
Truist Securities
Lowers
Hold
$71.00
$73.00
David Rescott
Truist Securities
Lowers
Hold
$71.00
$73.00
Adam Maeder
Piper Sandler
Lowers
Neutral
$71.00
$75.00
Mike Kratky
Leerink Partners
Announces
Market Perform
$71.00
-
Larry Biegelsen
Wells Fargo
Raises
Equal-Weight
$71.00
$68.00
David Rescott
Truist Securities
Raises
Buy
$73.00
$65.00
Key Insights:
Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or ...Full story available on Benzinga.com
Axonics (AXNX) delivered earnings and revenue surprises of 116.67% and 0.37%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.